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Expression of Protease-Activated Receptor-2 in SZ95
Sebocytes and its Role in Sebaceous Lipogenesis,
Inﬂammation, and Innate Immunity
Sang E. Lee1, Ji-Min Kim1, Se K. Jeong2, Eung H. Choi3, Christos C. Zouboulis4 and Seung H. Lee1
Protease-activated receptor-2 (PAR-2) functions as innate biosensor for proteases and regulates numerous
functions of the skin. However, the expression and physiological role of PAR-2 in sebocytes remain to be
elucidated. Here, we identiﬁed PAR-2 expression in SZ95 sebocytes at both mRNA and protein levels.
Intracellular Ca2+ mobilization by PAR-2 agonist peptide (PAR-2 AP) or Propionibacterium acnes (P. acnes) culture
supernatant was detected, indicating that P. acnes is a potent activator of PAR-2 on sebocytes. The small
interfering RNA (siRNA)–mediated PAR-2 knockdown in sebocytes resulted in defective differentiation and
lipogenesis. PAR-2 AP treatment enhanced lipogenesis and sterol response element-binding protein-1 (SREBP-1)
expression, suggesting a role of PAR-2 in the differentiation and lipogenesis of sebocytes. Moreover, PAR-2 AP
induced cytokines and human β-defensin-2 (hBD-2) transcription in sebocytes. PAR-2 expression was increased in
sebaceous glands of acne lesions. PAR-2 silencing by siRNA abrogated the increase in sebaceous lipogenesis and
SREBP-1 expression by P. acnes supernatant. PAR-2 knockdown also inhibited the P. acnes supernatant–induced
expression of cytokines and hBD-2. In conclusion, PAR-2 is expressed in SZ95 sebocytes and mediates
differentiation, lipogenesis, inﬂammation, and innate immunity in response to P. acnes. Therefore, PAR-2 might
be a therapeutic target for sebaceous gland disorders such as acne.
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INTRODUCTION
The skin is exposed to various endogenous and exogenous
proteases that have a role in skin physiology and patho-
physiology (Meyer-Hoffert, 2009). Certain serine proteases,
such as tryptase, kallikrein (KLK)-5, -6, and -14, or matriptase,
and various pathogen-derived proteases activate protease-
activated receptor-2 (PAR-2) in the skin, regulating perme-
ability barrier homeostasis, keratinocyte corniﬁcation,
pruritus, inﬂammation, pigmentation, and wound healing
(Rattenholl and Steinhoff, 2003, 2008; Hachem et al., 2006;
Demerjian et al., 2008).
Notably, previous studies have revealed that KLKs are not
only expressed in the interfollicular epidermis but also in the
pilosebaceous unit. Pro-KLK5 and KLK7 were identiﬁed in the
sebaceous ducts, suggesting a role in the desquamation-like
process at the pilosebaceous canal and sebaceous glands
(Ekholm et al., 1998, 2000). In another study, mRNA
expression of KLK-4, -6, -9, -10, and -11, and the serine
protease inhibitor Kazal-type 5 (SPINK5), was demonstrated in
the basal and inner mature cells in sebaceous glands
(Komatsu et al., 2003). In addition, KLK-6, -8, and -13 were
also found in sebaceous glands, especially in the cytoplasm of
basal cells (Komatsu et al., 2005). Coexpression of various
KLKs and SPINK5 in sebaceous glands suggests that the
balance between serine proteases and their inhibitor might
regulate sebocyte functions and mediate the pathophysiology
of diseases associated with sebaceous glands.
The sebaceous glands have a critical role in the pathogen-
esis of acne vulgaris (Makrantonaki et al., 2011). In the
lesional skin of acne, inﬁltration of activated mast cells
(Toyoda and Morohashi, 2003) and neutrophils (Kang et al.,
2005) was detected in adjacent areas to the sebaceous glands,
and these cells might produce proteases such as tryptase,
leukocyte elastase, and cathepsin G that are able to target
PAR-2 (Steinhoff et al., 1999, 2000; Uehara et al., 2003;
Moormann et al., 2006). Moreover, we have recently
demonstrated that proteases produced by a certain strain of
Propionibacterium acnes (P. acnes) activate PAR-2 on
keratinocytes and induce inﬂammatory cytokines, antimicro-
bial peptides, and matrix metalloproteinases, implicating an
involvement of PAR-2 signaling in acne pathogenesis (Lee
et al., 2010).
In human skin, PAR-2 is abundantly expressed by
keratinocytes; however, the expression and function of
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PAR-2 in sebaceous glands have not been systematically
investigated.
In this study, we identiﬁed the existence of functional
PAR-2 in SZ95 sebocytes and explored the role of PAR-2-
mediated signaling in sebaceous gland biology, such as
sebocyte differentiation, lipid synthesis, inﬂammation, and
innate immunity. In addition, we assessed whether P. acnes,
which produces extracellular proteases, is a potent activator
of PAR-2 in sebocytes via measuring Ca2+ signaling. Then, we
explored whether PAR-2 on SZ95 sebocytes is involved in the
recognition of P. acnes and mediates lipogenesis and the
expression of inﬂammatory cytokines and antimicrobial
peptides in response to P. acnes.
RESULTS
PAR-2 is expressed in the cultured human SZ95 sebocytes
First, we aimed to demonstrate the existence of PAR-2 in SZ95
sebocytes. To examine the localization of PAR-2 in SZ95
sebocytes, we used immunoﬂuorescent confocal microscopy.
Under basal conditions, PAR-2 was expressed at low levels in
a granular pattern within the cytoplasm of SZ95 sebocytes.
Combined treatment with 2×10−8 M testosterone and 10− 4 M
linoleic acid (T/LA) for 24 hours resulted in an increase in the
ﬂuorescence intensity of PAR-2, suggesting that PAR-2 expre-
ssion increases upon sebocyte differentiation (Figure 1a).
PAR-2 immunoﬂuorescence was observed within the cyto-
plasm, mainly around the cell periphery in a punctate staining
pattern (Figure 1a). PAR-2 expression on sebocytes at the
protein level was conﬁrmed by western blotting. By
western blotting, PAR-2 expression was increased in T/LA-
induced differentiated SZ95 sebocytes compared with undif-
ferentiated sebocytes (Figure 1b). We next investigated the
expression of PAR-2 at the gene level by real-time PCR using
PAR-2-speciﬁc primers that ampliﬁed a product of 491 bp and
real-time PCR. PAR-2 mRNA was detected in both undiffer-
entiated and differentiated SZ95 sebocytes (Figure 1c). Real-
time PCR data revealed that PAR-2 gene expression was
signiﬁcantly higher in the SZ95 sebocytes incubated with
T/LA compared with the undifferentiated sebocytes
(Figure 1d). Taken together, these data demonstrate the
existence of PAR-2 in human SZ95 sebocytes at both mRNA
and protein levels, with higher expression in more differ-
entiated cells after T/LA treatment.
Knockdown of PAR-2 suppresses sebocyte differentiation
To explore whether PAR-2 has a functional role in sebocyte
differentiation, we transfected SZ95 sebocytes with small
interfering RNAs (siRNAs) that speciﬁcally blocked PAR-2
expression (PAR-2 siRNA) or scrambled siRNA and subse-
quently treated the cells with T/LA for 24 hours. First, we
evaluated the efﬁciency of PAR-2 siRNA in SZ95 sebocytes.
Figure 2a shows that the transfection of SZ95 sebocytes with
PAR-2 siRNA signiﬁcantly decreased PAR-2 gene expression
by 63% and the scrambled siRNA, a negative control, had no
effect, demonstrating the speciﬁcity of the PAR2 siRNA
sequence. Western blot analysis showed that PAR-2 siRNA
transfection effectively reduced PAR-2 protein expression
(Figure 2b). Sebocyte differentiation was assessed by
measuring the mRNA levels of melanocortin receptor 5
(MC5R) and epidermal membrane antigen, as these genes are
expressed highly in the differentiated sebocytes (Zhang et al.,
2006; Zouboulis et al., 2008). Knockdown of PAR-2 by PAR-2
siRNA resulted in signiﬁcantly decreased MC5R and epider-
mal membrane antigen mRNA levels after T/LA treatment in
comparison with cells transfected with a scrambled control
(Figure 2c and d). Differentiation of sebocytes is accompanied
by the sebaceous lipid synthesis. Therefore, we also
investigated the effect of PAR-2 silencing on the T/LA-induced
lipid synthesis. As previously reported, T/LA treatment
enhanced the accumulation of lipid droplets and the synthesis
of neutral lipids in SZ95 sebocytes (Figure 2e and f), reﬂecting
stimulation of sebocyte differentiation (Wróbel et al., 2003),
whereas knockdown of PAR-2 by RNA interference signiﬁ-
cantly inhibited the T/LA-induced sebaceous lipid synthesis
compared with scrambled siRNA-transfected controls (Figure
2e and f). Taken together, these data strongly suggest that
PAR-2 signal exerts a critical role in sebocyte differentiation
and lipid accumulation, a key step in the differentiation of
sebocytes.
PAR-2 activation induces Ca2+ signaling in SZ95 sebocytes, and
P. acnes culture supernatant-induced calcium transient in
sebocytes is related to PAR-2 activation
To further determine the existence of functional PAR-2 on
sebocytes, we investigated whether PAR-2 on SZ95 sebocytes
is coupled to the intracellular calcium ([Ca2+]i) signaling.
SZ95 sebocytes were loaded with Ca2+-sensitive ﬂuorescence
dye fura 2 and stimulated with PAR-2 agonist peptide (PAR-2
AP). As shown in Figure 3a, the [Ca2+]i in sebocytes increased
rapidly with a peak at ∼ 40–60 seconds after stimulation with
PAR-2 AP in a dose-dependent manner. Repeated treatment
with PAR-2 AP reduced subsequent responses to the same
concentration of agonist peptide, suggesting that PAR-2 AP
activates and selectively desensitizes PAR-2 in sebocytes
(Figure 3b). PAR-2 AP–induced Ca2+ signaling was the same
in Ca2+-free solution as in normal solution, suggesting that
PAR-2 AP–induced [Ca2+]i increases were due to Ca
2+ release
from intracellular stores (Figure 3b and c).
We next investigated the ability of P. acnes to signal
(calcium transient) via PAR-2 in SZ95 sebocytes. Similar
increase in [Ca2+]i was detected in SZ95 sebocytes after
treatment with 2.5% concentration of P. acnes culture super-
natant (Figure 3d). Repeated stimulation with P. acnes super-
natant reduced subsequent responses (Figure 3e), suggesting
desensitization of the calcium signal. Removal of extracellular
Ca2+ and treatment with P. acnes supernatant also elicited a
similar increase in [Ca2+]i in sebocytes (Figure 3e and f).
To conﬁrm the PAR-2 dependence of P. acnes supernatant–
mediated Ca2+ signaling, we used siRNA to knockdown
PAR-2 expression. PAR-2 knockdown signiﬁcantly decreased
P. acnes supernatant–induced Ca2+ responses, whereas Ca2+
signaling persisted in scrambled siRNA-transfected controls
(Figure 3g). These results indicate that SZ95 sebocytes express
functional PAR-2 coupled to the intracellular calcium
signaling, and secreted P. acnes proteases can activate
PAR-2 on sebocytes.
SE Lee et al.
PAR-2 in SZ95 Sebocytes
2220 Journal of Investigative Dermatology (2015), Volume 135
PAR-2 expression is increased in sebaceous glands of acne
lesions
To verify the expression of PAR-2 in sebaceous glands of acne
lesions, the immunohistochemical evaluation of PAR-2 in
normal human facial skin and inﬂammatory acne-involved
facial skin samples was performed. Sebaceous glands of
inﬂammatory acne lesions expressed strong membranous and
intracytoplasmic staining of PAR-2 in almost all cells
(Figure 4). In sebaceous glands of the normal facial skin,
immunoreactivity of PAR-2 was less intense than in the biopsy
samples of the acne patients (Figure 4). These ﬁndings suggest
the possible involvement of PAR-2 signal in sebaceous glands
in the pathogenesis of acne.
PAR-2 activation enhances lipid synthesis and SREBP-1
expression in SZ95 sebocytes
To further explore the physiologic role of PAR-2 signaling in
sebocytes, we next aimed to investigate whether PAR-2
activation induces sebaceous lipid synthesis and cultured
undifferentiated and T/LA-induced differentiated SZ95 sebo-
cytes in the presence of PAR-2 AP or phosphate-buffered
saline (vehicle control) for 24 hours. In undifferentiated
sebocytes, PAR-2 AP did not signiﬁcantly affect lipogenesis,
whereas in T/LA-induced differentiated sebocytes stimulation
with PAR-2 AP signiﬁcantly increased lipid accumulation in
the cytoplasm compared with vehicle controls when exam-
ined by microscopy after semiquantitative Oil Red O
(Figure 5a) and quantitative Nile Red staining (Figure 5b).
To investigate the mechanism involved in the PAR-2
activation–induced sebaceous lipogenesis, we studied the
effect of PAR-2 AP on the expression of sterol response
element binding protein-1 (SREBP-1), the master regulator of
lipid biosynthesis, in sebocytes. Western blot analysis showed
that PAR-2 AP treatment signiﬁcantly increased the expression
of precursor and mature forms of SREBP-1 compared with
vehicle controls but did not alter the mature/precursor
SREBP-1 ratio (Figure 5d). In addition, real-time PCR
demonstrated that the SREBP-1a and -1c mRNA transcripts
were signiﬁcantly increased in the sebocytes in response to
PAR-2 AP (Figure 5e). These results suggest that SREBP-1
induction might be involved, at least in part, in the PAR-2
activation–induced lipogenesis in SZ95 sebocytes.
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Figure 1. Protease-activated receptor-2 (PAR-2) expression and localization in SZ95 sebocytes. (a) Immunoﬂuorescence staining of PAR-2 in the
undifferentiated (UnD-SZ95) and differentiated SZ95 sebocytes (D-SZ95) induced by 24 hours of treatment with testosterone/linoleic acid (T/LA). Nuclei
were counterstained by propidium iodide (red ﬂuorescence). Scale bar=50 μm. Insets of higher magniﬁcation show PAR-2 localization. Scale bar= 10 μm.
(b) Western blot for PAR-2 in undifferentiated and T/LA-differentiated sebocytes. (c) Total RNA of SZ95 sebocytes was isolated, reverse transcribed, and
subjected to PAR-2 real-time PCR (RT-PCR). Molecular markers were used to verify the sizes of RT-PCR products. β-Actin was used as an internal control.
(d) The mRNA levels of PAR-2 were analyzed by RT-PCR in undifferentiated and T/LA-differentiated SZ95 sebocytes. Data are shown as mean± SD of three
independent experiments (*Po0.05).
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Figure 2. Protease-activated receptor-2 (PAR-2) silencing by small interfering RNA (siRNA) transfection suppresses testosterone/linoleic acid
(T/LA)–induced sebocyte differentiation. SZ95 sebocytes were transfected with 50 nM PAR-2 siRNA or scrambled siRNA. At 24 hours after transfection,
PAR-2 mRNA and protein expression was evaluated using (a) real-time PCR and (b) western blotting, respectively, and differentiation was induced by T/LA
treatment for 24 hours. (c and d) The mRNA expression of sebocyte differentiation marker, melanocortin receptor 5 (MC5R), and epithelial membrane
antigen (EMA) was measured by real-time PCR. (e) Lipid accumulation was evaluated by Oil Red O staining. Scale bars=50 μm. (f) Quantitative analysis
of lipid synthesis was assessed by Nile Red staining followed by ﬂuorometric imaging plate reader (FLIPR) measurement. Values represent percentages of the
controls and show the mean± SD of three independent experiments (*Po0.05; **Po0.01).
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Figure 3. Intracellular calcium responses in SZ95 sebocytes stimulated with protease-activated receptor-2 agonist peptide (PAR-2 AP) or the culture
supernatant of Propionibacterium acnes. SZ95 sebocytes were loaded with Ca2+ indicator fura-2-AM, and ﬂuorescence measurements reﬂecting the
elevations of [Ca2+]i in response to various concentrations of (a) PAR-2 AP (1.25–5 μM) or (d) P. acnes supernatant (sup) were conducted using a ﬂuorescence
spectrometer. SZ95 sebocytes were desensitized with repeated treatment with (b) PAR-2 AP (2.5 μM) or (e) P. acnes sup. The [Ca2+]i signal in response
to (b and c) PAR-2 AP or (e and f) P. acnes sup in SZ95 sebocytes is shown in the presence and absence of 1.4 mM extracellular Ca2+. (g) P. acnes sup–induced
[Ca2+]i signals of PAR-2 small interfering RNA (siRNA)–transfected and scrambled RNA-transfected sebocytes. Fluorescence ratio, 340 nm/380 nm.
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Knockdown of PAR-2 inhibits P. acnes culture supernatant-
induced lipogenesis and SREBP-1 expression in SZ95 sebocytes
We demonstrated that the culture supernatant of P. acnes
activated PAR-2 in sebocytes. Therefore, we next examined
the involvement of PAR-2 signal in P. acnes–induced sebum
synthesis and SREBP-1 expression by siRNA-mediated PAR-2
silencing. Untransfected and PAR-2 siRNA– or scrambled
siRNA–transfected sebocytes were treated with T/LA to induce
differentiation and then incubated with P. acnes culture
supernatant or medium alone (control). P. acnes supernatant
signiﬁcantly increased lipid synthesis in SZ95 sebocytes
compared with control (Figure 5a and c). P. acnes supernatant
also enhanced the protein amount of SREBP-1 in both
precursor and mature forms in SZ95 sebocytes (Figure 5d).
The induction of lipid synthesis and SREBP-1 expression after
P. acnes stimulation were signiﬁcantly inhibited by PAR-2
silencing (Figure 5a, c, and d). These results suggest that
P. acnes, which has protease activity, activates PAR-2 on
sebocytes and induces lipogenesis partly via PAR-2 signal.
PAR-2 activation induces proinﬂammatory cytokines and hBD-2
transcription in SZ95 sebocytes, and P. acnes–induced
expression of cytokines and hBD-2 is attenuated by PAR-2
silencing
To further assess a role of PAR-2 in sebaceous gland
inﬂammation and innate immune response, we next investi-
gated whether PAR-2 signaling is involved in the production of
proinﬂammatory cytokines and antimicrobial peptides in SZ95
sebocytes. As shown in Figure 6a, signiﬁcant induction of IL-8
and tumor necrosis factor-α (TNF-α) mRNA expression was
observed in sebocytes stimulated with PAR-2 AP compared
with vehicle controls. Human β-defensin-2 (hBD-2) mRNA
level was signiﬁcantly upregulated after stimulation with
PAR-2 AP, whereas LL-37 transcript was not affected by
agonist treatment (Figure 6d). These results indicate a role of
PAR-2 in the regulation of inﬂammatory and innate immune
response in sebaceous glands. Then, we examined the
involvement of PAR-2 in P. acnes–induced cytokines and
hBD-2 mRNA expression in sebocytes by siRNA-mediated
knockdown of PAR-2. In line with the previous results, we
found that P. acnes culture supernatant induced the expression
of proinﬂammatory cytokines IL-8 and TNF-α in SZ95
sebocytes. In the transfected cells, P. acnes supernatant–
induced IL-8 and TNF-α mRNA expression was signiﬁcantly
inhibited by PAR-2-speciﬁc siRNA (Figure 6b and c). In
addition, PAR-2 siRNA inhibited P. acnes–induced increase in
gene expression of hBD-2 in sebocytes (Figure 6e). These
results suggest that P. acnes–induced production of proin-
ﬂammatory cytokines and hBD-2 in sebocytes is partly
mediated by PAR-2 signaling.
DISCUSSION
In this study, we identiﬁed that PAR-2 is present at the gene
and protein levels in SZ95 sebocytes, an immortalized human
sebaceous gland cell line. PAR-2 signals primarily by
coupling to the heterotrimeric G proteins, leading to a
transient increase in intracellular Ca2+. We also demonstrated
that PAR-2 AP triggers a transient rise in cytosolic Ca2+ in a
dose-dependent manner and repeated stimulation of agonist
peptide induces desensitization of [Ca2+]i mobilization in
SZ95 sebocytes, suggesting that PAR-2 is functionally active
in human sebocytes.
Functional studies demonstrated a role of PAR-2 for
sebocyte biology, including sebocyte differentiation, lipid
synthesis, and the gene expression of proinﬂammatory
cytokines and antimicrobial peptide.
The mRNA and protein levels of PAR-2 were higher in
T/LA-differentiated sebocytes compared with those in undif-
ferentiated cells, suggesting that increased expression of
PAR-2 might be related to the differentiation status of sebo-
cytes. However, to verify whether PAR-2 upregulation is
speciﬁc for T/LA treatment or a general phenomenon in the
process of sebocyte differentiation, further studies will be
needed. In addition, we observed that siRNA-mediated
silencing of PAR-2 signiﬁcantly inhibited T/LA-induced
expression of sebocyte differentiation markers and intra-
cellular lipid accumulation. These data strongly suggest that
PAR-2 signal has an important role in sebocyte differentiation
and associated lipid synthesis, the major step of the sebaceous
gland differentiation process. The involvement of PAR-2
signal in the regulation of the sebaceous lipid synthesis is
further supported by the increased lipogenesis in the differen-
tiated SZ95 sebocytes after stimulation with PAR-2 AP. Taken
together, these data suggest that, under physiological condi-
tions, certain extracellular proteases signal to sebocyte via
PAR-2 activation that contributes to sebocytes differentiation.
However, under pathologic conditions with enhanced local
Normal
facial skin 1 Acne 1
Acne 2
Acne 3
Normal
facial skin 2
Normal
facial skin 3
Figure 4. Expression of protease-activated receptor-2 (PAR-2) in the
sebaceous glands of acne lesions. Parafﬁn-embedded tissues of normal human
facial skin (n=5) and facial inﬂammatory acne lesions (n= 5) were
immunostained for PAR-2. Scale bars= 100 μm.
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levels of pathogen- or host-derived proteases such as
proteases from inﬂammatory inﬁltrates, sebocyte PAR-2
signaling may contribute to augment sebum production that
is pivotal in the pathogenesis of acne.
In addition, we observed an increase in the SREBP-1 mRNA
level and the amount of both precursor and mature forms of
SREBP-1 protein in SZ95 sebocytes after PAR-2 AP treatment,
suggesting that increased synthesis of SREBP-1 through PAR-2
signaling in sebocytes is a possible mechanism for the increase
in sebaceous lipogenesis in response to PAR-2 activation. The
SREBPs are key transcriptional factors that regulate genes
encoding enzymes of cholesterol and fatty acid synthesis in
sebaceous glands (Harrison et al., 2007), and the SREBP
pathway is known to be involved in the androgen and IGF-1-
mediated sebum production (Rosignoli et al., 2003; Smith
et al., 2008).
Previous studies have demonstrated that PAR-2 activation
contributes to cutaneous inﬂammation (Steinhoff et al., 2005).
In this study, we observed that PAR-2 activation via agonist
peptide signiﬁcantly enhanced IL-8 and TNF-α gene expres-
sion by SZ95 sebocytes, suggesting a role of PAR-2 signal
in mediating inﬂammatory responses in sebaceous glands.
Furthermore, recent evidence suggests that sebaceous glands
contribute to cutaneous immune defense by releasing
antimicrobial peptides or sebum-free fatty acids (Nagy et al.,
2006; Nakatsuji et al., 2010). Here, we demonstrated that
PAR-2 AP stimulation induced hBD-2 transcription in SZ95
sebocytes, indicating that PAR-2 signaling also mediates
innate immune responses in sebaceous glands.
Given our ﬁndings that PAR-2 mediates signals that
enhance lipid synthesis and inﬂammatory responses in SZ95
sebocytes, we hypothesized that PAR-2 in sebaceous glands
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lipogenesis and sterol regulatory element binding protein-1 (SREBP-1) expression in SZ95 sebocytes. Undifferentiated and testosterone/linoleic acid
(T/LA)–differentiated SZ95 sebocytes were treated with PAR-2 AP (2.5 μM) or phosphate-buffered saline (PBS; vehicle control) for 24 hours. SZ95 sebocytes
were transfected with scramble (sc) or PAR-2 small interfering RNA (siRNA). After induction of differentiation, P. acnes supernatant was added to the
culture medium (2.5%) and incubated for 24 hours. Lipid accumulation was evaluated by (a) Oil Red O and (b and c) Nile Red staining. Scale bars=50 μm.
(d) Western blot analysis for SREBP-1 and quantiﬁcation of the mature/precursor form ratio. (e) SREBP-1a and -1c mRNA levels were analyzed by real-time
PCR. Data represent the mean± SD of three independent experiments (*Po0.05; **Po0.01).
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may have a role in the pathogenesis of acne and studied the
expression of PAR-2 in sebaceous glands of inﬂammatory
acne lesional skin and compared it with facial biopsies from
healthy subjects. Our immunohistochemical data showed
strong upregulation of PAR-2 in the acne-involved sebaceous
glands compared with normal glands, implicating that
increased PAR-2 expression in sebocytes may contribute to
the pathogenesis of acne.
The exact endogenous activators of PAR-2 in sebocytes
have not been identiﬁed yet. In this study, we demonstrated
that the culture supernatant of P. acnes strain ATCC6919,
which was demonstrated to have protease activity in a
previous own study (Lee et al., 2010), activates PAR-2 in
SZ95 sebocytes by observing P. acnes–induced intracellular
calcium mobilization and receptor desensitization. PAR-2
activation by P. acnes in sebocytes is further supported by
the inhibition of P. acnes–induced Ca2+ signaling in SZ95
sebocytes after PAR2 siRNA transfection.
In addition, increased inﬁltration of activated mast cells and
neutrophils has been reported in acne lesional skin. Therefore, in
the inﬂammatory acne lesions, PAR-2 signaling in sebocytes may
be regulated by various possible activators including P. acnes–
secreted proteases, as well as mast cell tryptase or neutrophil
proteases (Uehara et al., 2003; Moormann et al., 2006).
Recent studies suggest that the activation of innate
immunity in keratinocytes and sebocytes by P. acnes and
subsequent proinﬂammatory responses are major factors for
the inﬂammatory reaction in acne vulgaris. Toll-like receptor
and PAR-2 represent two distinct receptors related to innate
immunity. Although Toll-like receptor-2–mediated cytokine
expression by P. acnes in sebocytes is known to be involved
in acne pathogenesis, the role of PAR-2 in mediating immune
response to P. acnes–secreted proteases has not been
addressed. Herein, we demonstrated that P. acnes culture
supernatant-induced IL-8 and TNF-α gene expression is medi-
ated by PAR-2 by observing a signiﬁcant decrease in
P. acnes–induced upregulation of these inﬂammatory cyto-
kines in PAR-2 siRNA–transfected sebocytes. In addition, we
noted that P. acnes–induced upregulation of hBD-2 occurred
via PAR-2. Certain phylogenetic groups of P. acnes are
pathogenic and may aggravate acne, but P. acnes is normally
a commensal bacterium that modulates the production of
antimicrobial peptides and inﬂammatory mediators, allowing
the skin to develop a protective certain level of innate
immunity (Zouboulis, 2009; Alexeyev et al., 2012). These
ﬁndings suggest that, under normal conditions, P. acnes/
PAR-2 signaling does not exert pathological effects and may
have a role in enhancing innate immunity and maintaining
homeostasis.
We also demonstrated that certain strain of P. acnes
participates in the enhancement of sebum production in
sebocytes through PAR-2 signaling. The role of P. acnes in the
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Figure 6. Protease-activated receptor-2 agonist peptide (PAR-2 AP) induces proinﬂammatory cytokines and human β-defensin-2 (hBD-2) transcription and
Propionibacterium acnes supernatant–induced increases in cytokines and hBD-2 were abrogated by PAR-2-speciﬁc small interfering RNA (siRNA) transfection
in SZ95 sebocytes. SZ95 sebocytes were treated with PAR-2 AP (2.5 μM) and the gene expression of (a) IL-8 and tumor necrosis factor-α (TNF-α) and
(d) antimicrobial peptide (hBD-2 and LL-37) was analyzed using real-time PCR. (b, c and e) Sebocytes were transfected with PAR-2 siRNA or scrambled
siRNA. At 24 hours after transfection, the medium was changed to complete medium with or without P. acnes supernatant at a ﬁnal concentration
of 2.5%. The mRNA expression of IL-8, TNF-α, and hBD-2 was evaluated 24 hours after stimulation using real-time PCR. Data are shown as mean± SD
of three independent experiments (*Po0.05; **Po0.01).
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sebaceous lipogenesis is still unclear (Zouboulis, 2009), but a
recent study demonstrated that P. acnes extract and formalin-
killed P. acnes (strains JCM 6473 and 6425) induced
lipogenesis in hamster sebaceous glands through an increase
in 15-deoxy-Δ12,14-prostaglandin J2 production (Iwata et al.,
2005). In this study, we observed that P. acnes supernatant
with protease activity increased lipid synthesis in sebocytes
and PAR-2 silencing by siRNA signiﬁcantly inhibited the
P. acnes supernatant–induced increase in lipogenesis and
SREBP-1 expression in SZ95 sebocytes. These ﬁndings suggest
that PAR-2 signaling is involved in and is at least partly
responsible for the enhancement of sebum production in
sebocytes in response to P. acnes.
In conclusion, we demonstrate that functional PAR-2 is
expressed in SZ95 sebocytes and mediates sebocyte differ-
entiation, lipogenesis, inﬂammation, and innate immunity.
This study also shows that P. acnes extracts activate PAR-2 in
SZ95 sebocytes and induce lipid synthesis and the expression
of proinﬂammatory cytokines and hBD-2 in sebocytes via
PAR-2 signaling. These data strongly suggest that PAR-2
regulates important physiological functions of sebocytes, and
the modulation of PAR-2 signaling might be a promising
therapeutic target for the treatment of disorders involving the
sebaceous glands such as acne vulgaris.
MATERIALS AND METHODS
Further details are available in Supplementary Materials and Methods
online.
Reagents and bacterial extracts
Human PAR-2 AP (SLIGKV-NH2) was purchased from Peptron
(Daejeon, Korea) and dissolved in phosphate-buffered saline. P. acnes
(ATCC 6919, Manassas, VA) was grown in the brain heart infusion
broth (Difco, Sparks, MD) at 37 °C for 24 hours under anaerobic
condition to log phase. Bacterial cultures were centrifuged at 5,000× g
for 15minutes. The supernatants were harvested, ﬁltered through a
0.2-μm pore size ﬁlter, and then stored at −20 °C until used.
Cell culture and differentiation induction
The immortalized human SZ95 sebaceous gland cell line (Zouboulis
et al., 1999) was cultured in DMEM/F-12 supplemented with 2mM
glutamax I, 10 μgml−1 gentamicin, 50 ngml− 1 human EGF, 10%
fetal bovine serum, and 10mM HEPES (all from Gibco BRL, Rockville,
MD). Cells were treated with the combination of 10-4 M linoleic
acid and 2× 10-8 M testosterone for 24 hours or maintained
for 24 hours in the medium. T/LA treatments induced cytoplasmic
lipid accumulation and the expression of epithelia membrane
antigen, suggesting the differentiation of sebocytes. Cells were
maintained at 37 °C/5% CO2 up to the third passage level, and the
medium was replaced every 2 days.
PAR-2 knockdown by RNA interference
For PAR-2 knockdown study, SZ95 sebocytes were transfected by
addition of transfection cocktail containing 50 nM PAR-2 siRNA using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA), according to the
manufacturer’s instructions. As a control, 50 nM siRNA control
sequence was transfected in the same procedure. The PAR-2 siRNA
construct was obtained as ON-TARGET plus SMART pool PAR2
(L-005095-00-0005), and the nontargeting siRNA control was
obtained as ON-TARGET plus siCONTROL nontargeting pool
(D-001810-10-05) from Dharmacon (Thermo Fisher Scientiﬁc,
Lafayette, CO). Cells were incubated for 24 hours at 37 °C, and the
efﬁciency of PAR-2 knockdown was evaluated by real-time PCR and
western blotting.
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